Abbreviations
A faster and more precise method for determining hibernating myocardium remains the holy grail of noninvasive cardiac imaging. Nuclear or echocardiogram-based imaging techniques have been the key modalities for evaluating important markers of cardiac viability. Advances in hardware and software for cardiac magnetic resonance imaging (CMRI) have transformed this valuable research tool into an important part of current noninvasive cardiac imaging. Due to its high spatial resolution and large field of view, CMRI offers unsurpassed images of the heart and its function. A combination of dobutamine stress function, vasodilator-induced stress perfusion, and delayed hyperenhancement of contrast within the injured myocardium has become a one-stop shop in the routine assessment of cardiac viability following transient ischemic insult or myocardial infarction. Curr Opin Cardiol 2002 , 17:663-670 © 2002 Lippincott Williams & Wilkins, Inc.
Myocardial dysfunction, more commonly known as heart failure, is a common clinical problem affecting more than 4.5 million patients in the United States. This number is expected to increase continuously as the average age of the general population continues to rise. Dysfunctional myocardium is made up of scarred tissue, viable tissue that is transiently hypocontractile, or a mixture of both. Scarring is a result of permanent damage to the cardiac muscle with replacement of normal cardiac myocytes by fibrotic tissue. Viable cardiac muscle that is transiently dysfunctional can be further divided into hibernating or stunned myocardium. Hibernating myocardium is a term used to describe dysfunctional cardiac muscle and the functional impairment due to chronic ischemia, which can be improved by either surgical or percutaneous revascularization [1, 2] . Myocardial hibernation involves an adaptive mechanism of self-protection from further ischemic insult. Hibernating cardiac myocytes downregulate their metabolic needs by an active process of selfpreservation to compensate for the decreased nutrient supply. On restoration of normal blood flow and nutritional substrates through revascularization or collateral formation, normal metabolic activity and contractile function resume. This reversible state of myocardial dysfunction is the implicit definition of hibernation. Distinct from hibernation, myocardial stunning refers to a form of myocardial contractile dysfunction occurring in response to a transient, but fully restored, cessation of blood flow. In myocardial stunning, no revascularization is needed, and full recovery of the cardiac function is expected but may take considerable time. Clinically, hibernation plays a major role in patients suffering from chronic stable angina or chronic ischemic cardiomyopathy, whereas stunned myocardium typically occurs in patients with unstable angina and immediately following thrombolysis or revascularization ( Fig. 1) 
Most patients with cardiac dysfunction have a combination of hibernating, stunned, or scarred tissue. The ability to differentiate and quantify the three types of tissue is the holy grail of today's noninvasive cardiac imaging. The long-term prognosis of patients with chronic ischemic cardiomyopathy is highly variable. The extent of viability, the ability to completely revascularize the stenotic lesions, and the recovery of the myocardial function following revascularization are three critical factors in determining the long-term prognosis of patients with ischemic heart disease. Clinicians rely heavily on the latest cardiac imaging modalities to help evaluate and to delineate those with significant viable and salvageable tissue. Timely referral of this group of patients for percutaneous or surgical revascularization will significantly improve their long-term survival. This article will begin with a brief review of the current concepts of chronic cardiac ischemia and viability. A summary of the conventional imaging modalities used for the assessment of cardiac ischemia and viability will be discussed.
Magnetic resonance imaging (MRI) has been transformed from a research tool for deciphering molecular structure to a useful clinical diagnostic modality found in every major hospital in this country. Development of MRI techniques for imaging of the cardiovascular system has lagged behind other systems due to the complex and continuous movement of the heart and its surrounding structures. Cardiac MRI (CMRI) has become a clinical reality in large part due to the rapid advances in coil and magnet design, higher processing speed of modern computer hardware and the ever advancing software development, improved pulse sequences, and better cardiac and respiratory gating systems. CMRI, due to its high spatial resolution and reproducibility, has become the gold standard for the assessment and quantification of myocardial thickness, mass, systolic and diastolic wall thickening, ejection fraction, global and regional wall motion, and function [4, 5] . This article will review the latest CMRI techniques used for evaluation of cardiac dysfunction and the potential of today's CMRI as the comprehensive, "one-stop-shop" evaluation of myocardial dysfunction.
Histopathologic diagnosis of myocardial dysfunction
Morphologic characteristics of hibernating myocardium include the loss of contractile proteins without substantial disruption of normal cellular integrity. These changes include the loss of cellular volume and glyco-gen-rich perinuclear zones adjacent to areas with numerous small mitochondria, the abnormal distribution throughout the nucleoplasm, and the substantial decrease in the number of sacroplasmic reticulum. These cellular changes are believed to represent the shift from active contractile tissue to a more stable, noncontractile state [6, 7] . Hibernation may be a state of degeneration rather than adaptation, with expression of properties reminiscent of the progression toward necrosis and fibrosis. Elsasser et al. [8] , using muscle biopsy at the time of revascularization, reported that hibernation is histologically consistent with a state of structural degeneration rather than adaptive stabilization with decreased mRNA expression and disorganization of the contractile and cytoskeleton proteins such as myosin, actin, desmin, alpha-actin, and vinculin. Furthermore, there was no evidence of dedifferentiation, such as the expression of fetal cardiac proteins [8] . Thus, functional recovery of dysfunctional myocardium is inversely proportional to the extent of myocardial fibrosis. Endocardial fibrosis of more than 30% of the total thickness of the myocardium correlates with poor functional recovery following revascularization [8] .
Myocyte apoptosis, programmed cell death, in hibernating myocardium is an interesting area of intense research. The presence of apoptotic cells in areas with myocardial hibernation has been described [8] [9] [10] . Apoptosis, without necrosis, signifies a state of controlled and stable existence in response to increasing levels of myocardial insult. Immediate revascularization will likely prevent progression to irreversible damage. In other words, myocardial hibernation represents a state of self-protection from further ischemic insult through downregulation of metabolic needs [2, 8, 10, 11] .
By decreasing intracellular and extracellular metabolic demands and reducing overall energy expenditure accordingly, these cells insulate themselves from the repetitive ischemic insults to which they are subjected. Once the oxygen and other nutritional substrates are replenished through revascularization or collateral vessel formation, the cells upregulate their metabolic activity and resume their normal contractile function.
Diagnosis of hibernating myocardium
Historically, clinicians have used various bedside methods to differentiate the viable and hibernating myocardium from the irreversibly damaged and scarred. Clinical history or symptoms of chronic stable angina is a timehonored and simple way of determining the presence of viable cardiac tissue. On the other hand, the presence of Q waves on surface electrocardiogram in the setting of acute myocardial infarction strongly suggests transmural irreversible damage. In contrast, the absence of Q waves and the presence of repolarization abnormalities of the S and T waves are highly suggestive of persistent cardiac ischemia. Invasive approach through pathologic sampling, by means of needle biopsy at the time of revascularization or myocardial explant at the time of cardiac transplant, generally is not practical and carries significant procedural risk. Furthermore, biopsy specimens can easily miss areas of hibernation. Postextrasystole potential of myocardial contractility is a useful maneuver for determining muscle viability. This maneuver can easily be carried out during routine cardiac catheterization in patients with angiographic evidence of diffuse or focal cardiac hypocontractility. Echocardiography may give additional clues to the presence of hibernating tissue. Areas of myocardium that are normal in thickness but fail to contract normally are highly suspicious for hibernation. This particular morphologic feature of hibernating myocardium is prominent in the areas surrounding the infarcted territories. Current noninvasive imaging techniques focusing on various important surrogates of hibernating myocardium, such as abnormalities in microvascular blood flow, contractile or perfusion reserve, and metabolic activity, have become an important part of cardiac diagnostic evaluation. Normal cardiac myocytes extract a near maximum amount of oxygen across all physiologic states. There is a direct link between oxygen delivery or blood flow and myocardial viability. The majority of nuclear imaging seeks to demonstrate certain pattern of blood flow to hibernating myocardium as compared with that of normal tissue. A summary of the specific markers of viability and the respective imaging modalities currently being used are shown in Table 1 .
Conventional imaging techniques for ischemic heart disease
Nuclear imaging: SPECT using thallium scintigraphy or technetium-99m sestamibi , an analogue of potassium, is actively taken up in exchange for sodium at the myocardial cell level. Uptake of thallium is an active and energyrequired process. Viable cell is a prerequisite for the uptake of this photon-emitting substance. The distribution of thallium is also proportional to blood flow to myocardial tissue beds and, as such, is a marker of blood flow. The ability to detect regional blood flow and cardiac myocyte membrane integrity is a unique strength of thallium imaging. Redistribution of thallium is one of the most sensitive methods for the demonstration of myocyte viability, with a sensitivity approaching 90% [12] .
Th-201 redistributes from the blood pool to the myocardium first to areas that have normal perfusion and later to those with decreased perfusion. Myocytes that are chronically hypoperfused but still metabolically active will take up thallium in proportion to their reduced blood flow but will equilibrate with the surrounding blood pool much more slowly than normal active myocytes. This property allows for the demonstration of areas of decreased perfusion on stress images that appear to recover on redistribution, especially with the reinjection of a small additional dose of thallium prior to the late imaging.
Sestamibi is an isonitrile that has a lower first pass extraction by the heart than thallium. The uptake of sestamibi also requires an intact cell membrane potential and sarcolemmal integrity. Sestamibi diffuses through the membrane and becomes nearly irreversibly bound to the negatively charged mitochondria of viable myocytes with a very low washout rate [13] . Because sestamibi does not redistribute appreciably, it is not very helpful in examining hibernating myocardium. However, demonstration of more than 50 to 60% uptake of the tracer by dysfunctional myocardium is considered to be indicative of myocardial viability. In comparison with its equivalent with thallium, sestamibi has a higher energy emission and a longer t 1 ⁄2, and thus it gives higher image quality.
However, the disadvantages of cardiac nuclear imaging include low spatial resolution, significant radiation exposure, and its relatively time-consuming procedure compared with other nonnuclear imaging modalities.
Dobutamine stress echocardiography
In echocardiography, identification of contractile dysfunction at rest without evidence of thin, fibrotic segmental abnormalities has been used as a potential marker of viable myocardium. Addition of a low-dose inotropic agent such as dobutamine at 5 to 10 µg/kg per minute has increased the diagnostic accuracy of echocardiography in determining viable myocardium. By detecting a surrogate marker of viability known as contractile reserve, dobutamine stress echocardiography (DSE) has the advantage of actually visualizing the function of the myocardial segments in question. The absence of response to low-dose dobutamine represents nonviable tissue. On the other hand, hibernating myocardium manifests a biphasic response to increasing doses of dobutamine. Hibernating myocardium contracts in response to a lowdose dobutamine infusion, but it becomes hypocontractile as the dose of dobutamine increases. High-dose dobutamine induces a greater demand on the hibernating muscle and outstrips the perfusion reserve due to the presence of significant proximal stenosis, resulting in a decrease of muscle contractility. The presence of the inducibility of this biphasic response correlates well with areas defined as hibernating by single photon emission computed tomography (SPECT) and positron emission tomography (PET) [12, 14] . This test is readily available without the need of heavy capital investment for the equipment. However, in about 10% of patients, it is difficult to obtain adequate images due to obesity, chronic lung disease, or chest wall deformity. Dobutamine stress transesophageal echocardiography (TEE), in theory, may overcome the inherent problems with transthoracic echocardiography. However, TEE itself is associated with its own procedural difficulties that limit the number of patients who are candidates for this stress imaging technique. Compared with nuclear imaging, the sensitivity of DSE is slightly lower. However, DSE has the best specificity for predicting functional improvement in response to revascularization (Table 2 ) [12, [15] [16] [17] .
Positron emission tomography
Positron emission tomography scanning is currently the gold standard for detecting myocardial viability. PET detects the activity of a positron emitter. Florine-18 fluorodeoxyglucose (F-18 FDG) is a glucose analogue that follows exogenous glucose uptake by the myocardium. PET scanning also provides information about coronary blood flow using radiolabeled nitrogen-13 (N-13) ammonia or rubidium-82. The demonstration of decreased flow as delineated by N-13 ammonia compared with metabolically active myocardium demonstrated by FDG is the hallmark of myocardial viability, the so-called PET mismatch. Viability is diagnosed when perfusion is normal or decreased and the uptake of F-18 FDG is normal or increased. Based on the results of the weighted mean values from available studies, Bax et al.
[18] reported a sensitivity of 88% and a specificity of 73% using F-18 FDG in predicting regional contractile improvement after revascularization in patients with ischemic left ventricular dysfunction. PET is slightly less specific than low-dose dobutamine echocardiography in determining viability. Like SPECT, PET has poor spatial resolution and can not differentiate endocardial from epicardial viability. Furthermore, its high cost and limited availability have impeded its widespread clinical utility.
Cardiac MRI: a one-stop shop for the evaluation of cardiac viability
Today, CMRI has emerged as a versatile imaging modality that may be the "one-stop-shop" solution in the evaluation of cardiac ischemia and hibernating myocardium. The distinct advantages of MRI over the current conventional nuclear-based imaging techniques, such as PET or thallium scintigraphy, include its exceptionally high spatial resolution and lack of any exposure to ionizing radiation. High spatial resolution allows clear visualization of endocardium and epicardium, which may be critical in delineating transmural from subendocardial scarred tissue or hibernating myocardium (Table 3) . MRI is more accurate quantitatively, and the images are more reproducible, independent of the operators or body anatomy.
Rest cine images of cardiac function
An essential feature of viable myocardium includes the preservation of normal contractile function. Viable myocardium may appear dysfunctional as a result of either acute reversible ischemic insults (myocardial stunning) or chronic gradual decrease in blood supply (hibernating myocardium). Myocardial wall thinning at rest is a reliable feature of scarred tissue resulting from extensive myocardial injury. The entire process of scarring usually takes about 4 months to develop from the time of acute injury [19] . Systolic wall thickening of more than 2 mm, as determined by ECG-gated breath-hold MR cine sequence, at rest or during dobutamine stress, is considered a reliable marker of viability [20] . Measuring wall thickness during end diastole, Baer et al.
[21] reported a cut-off value of 5.5 mm as the lower limit of myocardial wall thickness for the presence of viable myocardium. In addition, this study also reported that a thickness of less than 5.5 mm had a significantly decreased uptake of FDG on PET as compared with the regions with thickness of more than 5.5 mm [21] . Similar relation between wall thickness as determined by CMRI and viability was noted using postrevascularization functional wall motion improvement or Th-201 uptake as a marker of viability [22] [23] [24] . Thus, significant myocardial thinning and lack of endocardial thickening are reliable indicators of nonviable myocardial tissue.
Stress cine imaging with dobutamine or adenosine Dobutamine stress MRI for assessment of contractile reserve
Similar to DSE, dobutamine stress MRI evaluates an important parameter of muscle viability, ie, contractile reserve. DSE is an important diagnostic modality for the evaluation of residual viable myocardium in patients with suspected hibernation and in those after acute myocardial infarction. Low-and high-dose DSE images are useful for the assessment of myocardial viability. A biphasic response in which myocardial contractility increased at low dose and decreased at high dose is considered a good predictor of recovery of cardiac function following revascularization [25, 26] . Compared with echocardiography, cine CMRI has improved the accuracy of assessment of wall thickening [27,28•,29,30] . Cine cardiac MR tagging may further improve the diagnostic accuracy [31•]. Normal wall thickness without significant wall thickening during systole is a feature of myocardial stunning and hibernating myocardium. Low-dose dobutamine stimulation with the infusion of 5 to 10 µg/kg per minute of dobutamine together with cine cardiovascular MRI has been shown to be a reliable means of differentiating viable from nonviable myocardium. Higher doses of dobutamine (up to 40 µg/kg/min), with or without the addition of atropine at peak dose of dobutamine, are mainly used for evaluation of the presence of coronary stenosis or cardiac ischemia (Fig. 3) . Using the results of radiographic coronary angiography as a reference standard, Nagel et al.
[32] reported a sensitivity of 86% and a specificity of 86% with high-dose dobutamine in detecting significant coronary artery disease. Lauerma et al. [20] reported similar levels of sensitivity and specificity with dobutamine cine MRI in detecting viable myocardium in 10 patients with multivessel coronary artery disease who underwent MRI before and 6 months after coronary bypass surgery. This study used postoperative wall thickening as the standard for comparison. When dobutamine cine MRI was combined with first pass and late contrast enhancement, the sensitivity and specificity of the combined MR modality went up to 97% and 96%, respectively [20] . Failure of myocardial contractile augmentation in response to low-dose dobutamine stimulation does not necessarily exclude the presence of viable myocardial tissue because a larger quantity of viable myocytes is needed to maintain contractile reserve than to achieve significant uptake of radionuclide tracer [33••].
Adenosine stress MRI for evaluation of perfusion reserve
Gadolinium (Gd-DPTA) is useful as a contrast and perfusion agent. Gd-DPTA containing extracellular contrast is administered through a peripheral vein. Functional significance of any coronary artery lesion can be evaluated based on the effect on blood flow at rest and during stress testing using standard vasodilator agents. Viable myocardium exhibits gradual signal enhancement and washout with the passage of the T1-enhancing contrast agent (Fig. 2) . New or old infarcted myocardium exhibits decreased signal enhancement (hypoenhancement) on the first pass images and hyperenhancement on the delayed images (5-15 minutes after injection of Gd-DTPA) [34] . Perfusion imaging may help to distinguish stunning (normal or near-normal perfusion) from hibernating myocardium (hypoperfusion; Table 4 ). Addition of adenosine stress further accentuates the baseline perfusion defect in hibernating myocardium and helps differentiate normal from near-normal regions in stunned myocardium. Analogous to the detection of contractile reserve with low-dose dobutamine administration, vasodilatorinduced perfusion defects detect myocardial perfusion reserve. The presence of a hypoenhanced region surrounding or adjacent to hyperenhanced regions is consistent with the presence of the no-reflow phenomenon as a result of prolonged and persistent occlusion of the infarct-related vessel [35] . The no-reflow phenomenon is a persistent impairment of myocardial perfusion as a result of the irreversible damage to the microvasculature.
Delayed hyperenhancement of contrast agent
All the current conventional ultrasound and nuclearbased imaging modalities for the assessment of cardiac viability have one major limitation in that none can assess the transmural extent of viability in a damaged myo-cardium. Retention of contrast agent in the myocardium indicates the presence of nonviable myocardium regardless of the age of the infarct (Fig. 3) . In an experimental model, the presence of either early hypoenhancement or delayed hyperenhancement transmurally closely correlated with the loss of contractile reserve in response to low-dose dobutamine challenge [36••] . Kim et al. [37••] correlated the percent of transmural extent of late enhancement with the recovery of systolic wall thickening after surgical or percutaneous revascularization. The smaller the area of late enhancement, the higher the probability for mechanical improvement. Rogers et al.
[38] described three abnormal patterns on contrastenhanced MRI in the infarcted zones early after reperfused myocardial infarction (Table 4 ). Early first-pass hypoperfusion is associated with more extensive and irreversible damage with microvascular obstruction and 
One-stop-shop comprehensive evaluation of myocardial perfusion and function
Magnetic resonance imaging as a single imaging modality is capable of assessing cardiac function, perfusion, and viability-a task that usually required scintigraphy and echocardiology. In a study comparing MRI with FDG-PET in the assessment of cardiac viability, Lauerma et al.
[20] reported that the combination of dobutamine stress, first-pass perfusion, and late contrast enhancement was the best approach for detecting cardiac viability in patients with multivessel coronary artery disease. Sensky et al. [41••] developed and tested a protocol that evaluates myocardial perfusion, function, and hibernation in the same setting over a period of about 50 minutes (Table 5 ). This imaging protocol takes advantage of the short half life of adenosine (a vasodilator and thus a perfusion agent) and dobutamine (a positive inotropic agent) and allows for the infusion of both agents in a relatively short time interval to complete the function and perfusion analysis of the patient. This combined approach provides all the data required for the assessment of global and regional wall motion and the presence or absence of viable myocardium. The algorithm for the interpretation of the combined sets of data and their clinical implications is shown in Table 6 .
Conclusions
Cardiac MRI has gradually emerged as a multipurpose tool that all cardiologists are looking for. It not only provides images with high spatial resolution and a large field of view but also has developed into a user-friendly im-aging modality in large part due to the advances in the design of magnets and coils, gating techniques, pulse sequences, and postprocessing software. The clinical utility of CMRI is increasing everyday. Advances in fast cine cardiovascular MRI sequences permit rapid acquisition of cine images in one quick breath-hold. Development of user-friendly software for real-time imaging allows continuous monitoring of any changes in cardiac motion during inotropic stimulation. Radial imaging may further shorten the image acquisition time and may eliminate the need of breath-hold and perhaps the need of ECG gating. Currently the major limitations of CMRI include high initial equipment and installation cost, small number of trained specialists in operating and interpreting the images, lack of MRI scanners equipped with specialized accessories for cardiac scanning, and the relatively lengthy time for image acquisition. Cardiac dysfunction is a common clinical problem that is going to affect more and more people everyday as the average age of the population continues to increase. The ability to assess function, perfusion, and viability at one setting in less than 1 hour has made CMRI an appealing and costeffective modality for the initial evaluation of ischemic heart disease. As the general acceptance and third party reimbursement rate for performing CMRI continues to increase, this former research tool of organic chemists may finally become a part of everyday clinical cardiology practice.
